Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Sectra AB (publ)
  6. News
  7. Summary
    SECT B   SE0014609061

SECTRA AB (PUBL)

(SECT B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sectra publ : FDA clearance-Sectra's digital pathology solution available for primary diagnostics and remote reading in the U.S.

04/01/2020 | 02:32am EDT

Linköping, Sweden and Shelton, CT - April 1, 2020 - International medical imaging IT and cybersecurity company Sectra (https://sectra.com/) (STO: SECT B) has received a 510(k) clearance by the US Food & Drug Administration (FDA). The clearance applies for Sectra Digital Pathology Module, the key component of Sectra's pathology solution, when used together with Leica Biosystems' scanner AT2 DX. This enables US healthcare providers to use Sectra's digital pathology solution for primary diagnostics. The solution makes it possible to move towards fully integrated diagnostics, which is especially important in complex cancer cases.

"I'm excited that with the FDA approval, we are now able to offer US healthcare providers a digital pathology offering with a proven track-record of use for full-scale primary diagnostics and large volumes," says Mikael Anden, President, Sectra Inc. "Our solution makes it possible for pathologists across the country to continue their important work from home without the need for a microscope. We look forward to providing uninterrupted pathology reading in these challenging times. This approval is an exciting and important step forward for pathology and cancer care in the US." 

Sectra's digital pathology solution is already used in the US for research and tumor boards and can now also be used in primary diagnostics. With digital images of tissue samples instead of physical glass slides, pathologists gain instant access to current and historical images and related data as well as to digital tools for reviewing the images. Digital access also facilitates efficient second opinions, remote reading, specialist consultations and makes integrated diagnostics possible.

The digital pathology solution is a component of Sectra's enterprise imaging offering, of which all components are built on the same technical platform. This allows healthcare providers to use a single solution for their medical imaging needs across all specialties, enabling integrated diagnostics. A deeper cooperation and ability to access other departmental images and information contributes to improved efficiency and patient care. This is especially important for complex cases where both radiology and pathology play key roles. Instant access to digital pathology images, side by side with radiology or other images, enables more efficient discussions and the ability to give detailed descriptions of findings.

"Pathology is the next huge digitization of healthcare. The use of glass slides limits growth in today's increasingly digital environment, especially in consolidated health care systems where potential synergies cannot be reached unless pathology is digitized. Our solution opens up new opportunities in the US where we can point to our successes in Europe in large production centers," says Dr. Torbjörn Kronander, President and CEO of Sectra.

Watch this video (https://youtu.be/g_oXh4kp770) to learn more about how digital pathology can enable increased efficiency and higher precision for the pathologists. 

About Sectra Imaging IT Solutions
With more than 30 years of innovation and 2,000 installations worldwide, Sectra is a leading global provider of imaging IT solutions that support healthcare in achieving patient-centric care. Sectra offers an enterprise imaging solution comprising PACS for imaging-intense departments (radiology, pathology, cardiology, orthopedics), VNA, and share and collaborate solutions. Read more about Sectra and why Sectra PACS is "Best in KLAS" for a seventh consecutive year at https://medical.sectra.com/.
 

For further information, please contact:
Dr. Torbjörn Kronander, CEO and President Sectra AB, +46 (0)705 23 52 27
Marie Ekström Trägårdh, Executive Vice President Sectra AB and President Sectra Imaging IT Solutions, +46 (0)708 23 56 10

About Sectra
Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society's most sensitive information. Thereby, Sectra contributes to a healthier and safer society. The company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2018/2019 fiscal year totaled SEK 1,413 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit https://sectra.com/.

https://news.cision.com/sectra/r/fda-clearance-sectra-s-digital-pathology-solution-available-for-primary-diagnostics-and-remote-readi,c3078280

https://news.cision.com/sectra/i/sectra-digital-pathology-solution,c2768074

(c) 2020 Cision. All rights reserved., source Press Releases - English

All news about SECTRA AB (PUBL)
04/16SECTRA  : Change to the Nomination Committee of Sectra AB (publ)
AQ
04/15SECTRA  : Swedish healthcare region replaces IT solution to improve medical imag..
PU
04/15SECTRA  : Swedish healthcare region replaces IT solution to improve medical imag..
AQ
04/13SECTRA  : VNA and universal viewer for all enterprise imaging selected by UC Hea..
PU
04/13SECTRA  : VNA and universal viewer for all enterprise imaging selected by UC Hea..
AQ
03/25SECTRA  : French hospital specialized in neuroscience chooses Sectra's digital p..
PU
03/25SECTRA  : French hospital specialized in neuroscience chooses Sectra's digital p..
AQ
03/22SECTRA  : helps civil authorities and large corporations protect their digital c..
AQ
03/12SECTRA'S NINE-MONTH INTERIM REPORT 2 : Increased order bookings and the industry..
AQ
03/11SECTRA'S NINE-MONTH INTERIM REPORT 2 : Increased order bookings and the industry..
PU
More news
Financials
Sales 2021 1 651 M 196 M 196 M
Net income 2021 250 M 29,6 M 29,6 M
Net cash 2021 355 M 42,2 M 42,2 M
P/E ratio 2021 90,4x
Yield 2021 0,85%
Capitalization 22 595 M 2 677 M 2 679 M
EV / Sales 2021 13,5x
EV / Sales 2022 11,4x
Nbr of Employees 819
Free-Float 67,0%
Chart SECTRA AB (PUBL)
Duration : Period :
Sectra AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SECTRA AB (PUBL)
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Average target price 609,50 SEK
Last Close Price 586,50 SEK
Spread / Highest target 22,6%
Spread / Average Target 3,92%
Spread / Lowest Target -14,7%
EPS Revisions
Managers and Directors
NameTitle
Clas Harald Torbjörn Kronander President, Chief Executive Officer & Director
Mats Franzén Chief Financial Officer
Jan-Olof Vilhelm Arn Brüer Chairman
Per Andersnäs Chief Information Officer
Christer Nilsson Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
SECTRA AB (PUBL)-20.04%2 677
VEEVA SYSTEMS INC.1.31%41 568
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED-2.84%38 594
OMNICELL, INC.14.85%5 951
PRO MEDICUS LIMITED36.94%3 769
CLOVER HEALTH INVESTMENTS, CORP.-47.41%3 567